Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
422.35
Change Change %
8.70 2.10%

Updated:20 Feb, 2019, 15:59 PM IST

BSE
422.20
Change Change %
7.85 1.89%

Updated:20 Feb, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nomura
N/A
08-12-2015 Hold 775.00 817.00
N/A
Target Hit Custom
08-12-2016

Nomura upgrades Sun Pharma to neutral

Gleevec approval is in-line with expectation. Failure to scale speciality business presents a downside risk to long-term growth assumptions, hence valuation multiples. Regulatory update on Halol facility and realisation of Ranbaxy synergy are the key catalysts for the stock.

Top